{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05669482",
            "orgStudyIdInfo": {
                "id": "VS-6766-205"
            },
            "organization": {
                "fullName": "Verastem, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer",
            "officialTitle": "A Phase 1b/2a Study of Gemcitabine and Nab-paclitaxel in Combination With Avutometinib (VS-6766) and Defactinib in Patients With Previously Untreated Metastatic Adenocarcinoma of the Pancreas",
            "acronym": "RAMP205",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "study-of-avutometinib-vs-defactinib-with-gemcitabine-and-nab-paclitaxel-in-patients-with-pancreatic-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-12-06",
            "studyFirstSubmitQcDate": "2022-12-19",
            "studyFirstPostDateStruct": {
                "date": "2022-12-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Verastem, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will assess the safety and efficacy of avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreated.",
            "detailedDescription": "This is a multicenter, non-randomized, open-label Phase 1/2 study designed to evaluate safety, tolerability and efficacy of avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel in patients previously untreated metastatic Pancreatic Ductal Adenocarcinoma (PDAC)."
        },
        "conditionsModule": {
            "conditions": [
                "KRAS Activating Mutation",
                "Metastatic Cancer",
                "Pancreas Cancer",
                "Neoplasms Pancreatic",
                "Malignant Neoplasm of Pancreas"
            ],
            "keywords": [
                "avutometinib (VS-6766)",
                "Metastatic Cancer",
                "KRAS Mutation",
                "Pancreatic Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Gemcitabine + nab-paclitaxel + avutometinib (VS-6766) + defactinib",
                    "type": "EXPERIMENTAL",
                    "description": "To determine the recommended phase 2 dose (RP2D) for gemcitabine Gemcitabine + nab-paclitaxel + avutometinib (VS-6766) + defactinib in patients with untreated metastatic PDAC.",
                    "interventionNames": [
                        "Drug: avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel"
                    ]
                },
                {
                    "label": "Gemcitabine + nab-paclitaxel + avutometinib (VS-6766) + defactinib RP2D",
                    "type": "EXPERIMENTAL",
                    "description": "To determine the efficacy of the RP2D identified in Part A in untreated metastatic PDAC patients",
                    "interventionNames": [
                        "Drug: avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel",
                    "description": "The RP2D of avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel determined in Part A will be used in Part B dose expansion.",
                    "armGroupLabels": [
                        "Gemcitabine + nab-paclitaxel + avutometinib (VS-6766) + defactinib",
                        "Gemcitabine + nab-paclitaxel + avutometinib (VS-6766) + defactinib RP2D"
                    ],
                    "otherNames": [
                        "Gemzar",
                        "Abraxane"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part A: To determine RP2D for avutometinib (VS-6766) and defactinib in combination gemcitabine and nab-paclitaxel",
                    "description": "Assessment of Dose-limiting toxicities (DLTs)",
                    "timeFrame": "28 days"
                },
                {
                    "measure": "To determine the efficacy of the RP2D identified in Part A",
                    "description": "Confirmed overall response rate (ORR) (partial response \\[PR\\] + complete response \\[CR\\] defined according to Response Evaluation Criteria in Solid Tumors version 1.1 \\[RECIST 1.1\\])",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Duration of Response (DOR)",
                    "description": "Time of first response to PD as assessed per RECIST 1.1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Disease Control Rate (DCR)",
                    "description": "CR + PR + SD as assessed per RECIST 1.1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Progression Free Survival (PFS)",
                    "description": "From the time of first dose of study intervention to PD as assessed per RECIST 1.1 or death from any cause",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "From the time of first dose of study intervention to PD as assessed per RECIST 1.1 or death from any cause",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Plasma Pharmacokinetics (PK) of avutometinib (VS-6766) and Defactinib and relevant metabolites, Tmax",
                    "description": "Time to Maximum concentration (Tmax)",
                    "timeFrame": "10 weeks"
                },
                {
                    "measure": "Plasma Pharmacokinetics (PK) of avutometinib (VS-6766) and Defactinib and relevant metabolites, AUC",
                    "description": "Area under plasma Concentration (AUC) 0 to t",
                    "timeFrame": "10 Weeks"
                },
                {
                    "measure": "Plasma Pharmacokinetics (PK) of avutometinib (VS-6766) and Defactinib and relevant metabolites, Half-life",
                    "description": "concentration Half-life (T1/2)",
                    "timeFrame": "10 weeks"
                },
                {
                    "measure": "Frequency and severity adverse events (AEs) and Serious Adverse Events (SAEs)",
                    "description": "Count of AE and SAEs by grade, based on the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) grading scale",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Number of abnormal laboratory values",
                    "description": "Count of abnormal laboratory values by grade",
                    "timeFrame": "24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female subjects \u2265 18 years of age\n* Histologic or cytologic evidence of metastatic pancreatic ductal adenocarcinoma.\n* An Eastern Cooperative Group (ECOG) performance status \u2264 1\n* Measurable disease according to RECIST 1.1\n* Adequate organ function\n* Adequate cardiac function\n* Agreement to use highly effective method of contraceptive\n\nExclusion Criteria:\n\n* Patients with pancreatic neuroendocrine tumors\n* Prior or concomitant treatment for metastatic pancreatic ductal adenocarcinoma\n* Prior treatment with inhibitors of the RAS /MAPK pathway \\[e.g. MEK inhibitors\\] or inhibitors of FAK\n* History of prior malignancy, with the exception of curatively treated malignancies\n* Major surgery within 4 weeks (excluding placement of vascular access)\n* Concurrent heart disease or severe obstructive pulmonary disease\n* Concurrent ocular disorders\n* Active skin disorder that has required systemic therapy within the past 1 year\n* Patients with interstitial lung disease or pulmonary fibrosis or severe lung disease, pulmonary edema, and adult respiratory distress syndrome\n* Known SARS-Cov2 infection \u226428 days prior to first dose of study therapy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Verastem Call Center",
                    "role": "CONTACT",
                    "phone": "1 781 292 4204",
                    "email": "clinicaltrials@verastem.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "MD Verastem",
                    "affiliation": "Verastem, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "UCSF Helen Diller Family Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94158",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Insiyah Merchant",
                            "role": "CONTACT",
                            "email": "insiyah.merchant@ucsf.edu"
                        },
                        {
                            "name": "Andrew Ko, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "University of Chicago",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Trials",
                            "role": "CONTACT",
                            "phone": "855-702-8222",
                            "email": "clinicaltrials@bsd.uchicago.edu"
                        },
                        {
                            "name": "Shergill Ardaman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kimberly Perez",
                            "role": "CONTACT",
                            "phone": "617-632-6491",
                            "email": "Kimberly_Perez@DFCI.HARVARD.EDU"
                        },
                        {
                            "name": "Kimberly Perez, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Michigan Cancer Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cancer AnswerLine\u2122",
                            "role": "CONTACT",
                            "phone": "800-865-1125",
                            "email": "CancerAnswerLine@med.umich.edu"
                        },
                        {
                            "name": "Arathi Mohan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lynne Mitchell",
                            "role": "CONTACT",
                            "phone": "314-273-6758",
                            "email": "lynne.mitchell@wustl.edu"
                        },
                        {
                            "name": "Kian-Huat Lim, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Laura & Isaac Perlmutter Cancer Center at NYU Langone Health",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kristen Spencer",
                            "role": "CONTACT",
                            "phone": "212-731-6000",
                            "email": "Kristen.Spencer@nyulangone.org"
                        },
                        {
                            "name": "Kristen Spencer, DO",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "New York Presbyterian/Weill-Cornell Medical Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Casey Owens",
                            "role": "CONTACT",
                            "email": "cdo4001@med.cornell.edu"
                        },
                        {
                            "name": "Despina Siolas, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anna Varghese, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Luda Mazaleuskya",
                            "role": "CONTACT",
                            "phone": "267-455-9141",
                            "email": "mazali@pennmedicine.upenn.edu"
                        },
                        {
                            "name": "Mark O'Hara, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "University of Utah Huntsman Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84112",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sierra Mitchell",
                            "role": "CONTACT",
                            "phone": "801-313-5655",
                            "email": "Sierra.Mitchell@hci.utah.edu"
                        },
                        {
                            "name": "Ignacio Garrido-Laguna",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "Virginia Mason Medical Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98101",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Colleen Soleau",
                            "role": "CONTACT",
                            "phone": "206-287-6272",
                            "email": "Colleen.Soleau@vmfh.org"
                        },
                        {
                            "name": "Vincent Picozzi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rachael Safyan",
                            "role": "CONTACT",
                            "phone": "206-606-2038",
                            "email": "rsafyan2@fredhutch.org"
                        },
                        {
                            "name": "Rachael Safyan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009362",
                    "term": "Neoplasm Metastasis"
                },
                {
                    "id": "D000010190",
                    "term": "Pancreatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009385",
                    "term": "Neoplastic Processes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "asFound": "Malignant Neoplasm of Pancreas",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "asFound": "Metastatic Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12330",
                    "name": "Neoplastic Processes",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "asFound": "Malignant Neoplasm of Pancreas",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017239",
                    "term": "Paclitaxel"
                },
                {
                    "id": "D000093542",
                    "term": "Gemcitabine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M19537",
                    "name": "Paclitaxel",
                    "asFound": "Sessions",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2985",
                    "name": "Gemcitabine",
                    "asFound": "Mg/kg",
                    "relevance": "HIGH"
                },
                {
                    "id": "M231",
                    "name": "Albumin-Bound Paclitaxel",
                    "relevance": "LOW"
                },
                {
                    "id": "M22554",
                    "name": "Pancrelipase",
                    "relevance": "LOW"
                },
                {
                    "id": "M13114",
                    "name": "Pancreatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}